Madrigal Pharmaceuticals (MDGL) Fair Value & DCF

MDGL$427.39+2.18 +0.51%
BiotechnologyGrowth Stock
Compare
Market cap$9.93BEnterprise value$9.09BRevenue (TTM)$1.43BMarket position—

Score

65
Bullish
Value
50
Quality
44
Growth
100

Madrigal Pharmaceuticals, Inc. (MDGL) trades at $427.39 on $9.93B of equity value, with a trailing P/E of -67.75. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Madrigal Pharmaceuticals (MDGL) Fair Value & DCF

MDGL price $427.39 +2.18 +0.51%

Ticker
MDGL
Price
$427.39
Change
+2.18 +0.51%
Market cap
$9.93B
Forward P/E
87.44
Dividend yield
0.00%
Beta
-1.00
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
50
Quality
44
Growth
100

Stocklytics score rationale: value 50, quality 44, growth 100.

AI Score 45. Madrigal Pharmaceuticals, Inc. has a high price of $396.32 and a market cap of $9.16 billion, but it is in the clinical development phase with negative margins, including a net profit margin of -0.1089

Insights · Forecast · Financials · Learn

Stocklytics home · Screener